Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Genetic overlap between treatment-resistant schizophrenia and smoking initiation.

The international journal of neuropsychopharmacology·2026
Same author

Prognostic relevance of β1-adrenergic receptor polymorphisms on cardiovascular outcome in patients treated with metoprolol after acute myocardial infarction - an observational study.

European journal of clinical pharmacology·2026
Same author

The 8th European Society of Pharmacogenomics and Personalized Therapy (ESPT) congress.

Pharmacogenomics·2026
Same author

Navigating ADME profiling challenges in microphysiological systems: Evaluation of a liver-chip model for clearance prediction.

Journal of pharmaceutical sciences·2026
Same author

Acute Liver Failure With Transient Liver Steatosis Following Multiple Hits Postoperatively in a Patient With Limb-Girdle Muscular Dystrophy: A Case Report.

Clinical case reports·2026
Same author

Pharmacokinetic recall study of Estonian Biobank participants with novel genetic variants in CYP2C19 and CYP2D6.

NPJ genomic medicine·2026

Related Experiment Video

Updated: Nov 3, 2025

Human Liver Spheroids from Peripheral Blood for Liver Disease Studies
09:51

Human Liver Spheroids from Peripheral Blood for Liver Disease Studies

Published on: January 27, 2023

2.0K

Primary human hepatocyte spheroids as an .

Julia Riede1, Birgit M Wollmann2, Espen Molden3

  • 1Drug Metabolism and Pharmacokinetics, Novartis Institutes for Biomedical Research, Switzerland.

Drug Metabolism and Disposition: the Biological Fate of Chemicals
|June 2, 2021
PubMed
Summary

Primary human hepatocyte spheroids accurately predict drug hepatic clearance. This 3D model overcomes limitations of traditional in vitro systems for slowly metabolized drug compounds.

Keywords:
clearanceclinical pharmacokineticscytochrome P450

More Related Videos

Author Spotlight: Harnessing Mouse Eye Chambers for Noninvasive Liver Spheroid Studies
05:27

Author Spotlight: Harnessing Mouse Eye Chambers for Noninvasive Liver Spheroid Studies

Published on: March 29, 2024

1.5K
A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma
12:24

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma

Published on: September 30, 2021

5.6K

Related Experiment Videos

Last Updated: Nov 3, 2025

Human Liver Spheroids from Peripheral Blood for Liver Disease Studies
09:51

Human Liver Spheroids from Peripheral Blood for Liver Disease Studies

Published on: January 27, 2023

2.0K
Author Spotlight: Harnessing Mouse Eye Chambers for Noninvasive Liver Spheroid Studies
05:27

Author Spotlight: Harnessing Mouse Eye Chambers for Noninvasive Liver Spheroid Studies

Published on: March 29, 2024

1.5K
A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma
12:24

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma

Published on: September 30, 2021

5.6K

Area of Science:

  • Pharmacology
  • Drug Metabolism
  • Hepatocyte Biology

Background:

  • Traditional in vitro systems like liver microsomes and hepatocytes have limited stability for assessing drug metabolism.
  • This instability restricts the evaluation of drug compounds with slow metabolic turnover rates.

Purpose of the Study:

  • To evaluate 3D primary human hepatocyte spheroids for predicting hepatic clearance of drugs.
  • To assess the stability and predictive capability of hepatocyte spheroids for drug candidates with low to intermediate human clearance.

Main Methods:

  • Incubation of 3D primary human hepatocyte spheroids with seven drugs.
  • Monitoring parent drug depletion over seven days.
  • Comparison of predicted hepatic clearance with clinical data.

Main Results:

  • Hepatocyte spheroids maintained an in vivo-like phenotype during prolonged incubations (7 days).
  • Pooling spheroids led to fusion and de-differentiation, limiting its quantitative use.
  • Predicted hepatic clearance correlated well with clinical data (6/7 drugs within 3-fold deviation).

Conclusions:

  • 3D primary human hepatocyte spheroids provide accurate hepatic clearance predictions for slowly metabolized drugs.
  • This model is a valuable tool for pharmacokinetic studies of new drug candidates.
  • Hepatocyte spheroids overcome limitations of traditional in vitro models for drug metabolism assessment.